Resultados de la búsqueda - Portal de Modelos de Datos Médicos (MDM-Portal)

Filtrar resultados de búsqueda
Seleccionar modelos de datos

Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

112 Resultados de la búsqueda.

Eligibility Lymphoma NCT00770224

- 13.07.20 - 1 formulario, 1 itemgroup, 21 items, 1 idioma

Itemgroup: Criteria

S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00770224

Eligibility Relapsed Peripheral T-Cell Lymphoma NCT02464228

- 29.06.19 - 1 formulario, 2 itemgroups, 33 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02464228

Eligibility Relapsed or Refractory EBV-and CD30-positive Lymphomas NCT02388490

- 29.06.19 - 1 formulario, 2 itemgroups, 26 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Brentuximab Vedotin in Patients With Relapsed or Refractory EBV-and CD30-positive Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT02388490

Eligibility Primary Central Nervous System Lymphoma NCT02399189

- 14.06.19 - 1 formulario, 2 itemgroups, 16 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

MT-R Followed by Autologous Stem Cells Transplantation in Newly-diagnosed Primary Central Nervous System Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02399189

Eligibility Lymphomas NCT02274584

- 03.05.19 - 1 formulario, 2 itemgroups, 19 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273); ODM derived from: https://clinicaltrials.gov/show/NCT02274584

Eligibility Lymphoma NCT02494700

- 30.04.19 - 1 formulario, 2 itemgroups, 15 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Ultra Low Dose 4 Gy Orbital Radiation for Definitive Therapy of Indolent B Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT02494700

Eligibility Lymphoma NCT02488382

- 30.04.19 - 1 formulario, 2 itemgroups, 11 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Lonquek for Autologous Stem Cell Mobilization; ODM derived from: https://clinicaltrials.gov/show/NCT02488382

Eligibility Lymphoma NCT02405078

- 30.04.19 - 1 formulario, 2 itemgroups, 16 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Pilot Project for Creation of the Diffuse Large B-cell Lymphoma (DLBCL) Response Prediction Model; ODM derived from: https://clinicaltrials.gov/show/NCT02405078

Eligibility Lymphoma NCT01974440

- 30.04.19 - 1 formulario, 2 itemgroups, 20 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

A Study of PCI-32765 (Ibrutinib) in Combination With Either Bendamustine and Rituximab or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Participants With Previously Treated Indolent Non-Hodgkin Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT01974440

Eligibility Precursor Lymphoid Neoplasms NCT01665001

- 14.01.19 - 1 formulario, 2 itemgroups, 10 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Personalized Therapy of Precursor Lymphoid Neoplasms; ODM derived from: https://clinicaltrials.gov/show/NCT01665001

Eligibility Lymphoma NCT02072655

- 05.01.19 - 1 formulario, 2 itemgroups, 9 items, 1 idioma

Itemgroups: Inclusion Criteria, Exclusion Criteria

Impact of Socio-aesthetic Care in the Quality of Life of Patients Treated for Lymphoma During and After Hospitalization; ODM derived from: https://clinicaltrials.gov/show/NCT02072655

Eligibility Lymphoma NCT02038946

- 04.01.19 - 1 formulario, 3 itemgroups, 8 items, 1 idioma

Itemgroups: Criteria, Inclusion Criteria, Exclusion Criteria

Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140); ODM derived from: https://clinicaltrials.gov/show/NCT02038946

Utilice este formulario para comentarios, preguntas y sugerencias.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.